AU5243198A - Enhancement of tumor cell chemosensitivity and radiosensitivity using single chain intracellular antibodies - Google Patents
Enhancement of tumor cell chemosensitivity and radiosensitivity using single chain intracellular antibodiesInfo
- Publication number
- AU5243198A AU5243198A AU52431/98A AU5243198A AU5243198A AU 5243198 A AU5243198 A AU 5243198A AU 52431/98 A AU52431/98 A AU 52431/98A AU 5243198 A AU5243198 A AU 5243198A AU 5243198 A AU5243198 A AU 5243198A
- Authority
- AU
- Australia
- Prior art keywords
- radiosensitivity
- enhancement
- tumor cell
- single chain
- intracellular antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2967396P | 1996-10-30 | 1996-10-30 | |
| US60029673 | 1996-10-30 | ||
| PCT/US1997/019911 WO1998018489A1 (en) | 1996-10-30 | 1997-10-30 | Enhancement of tumor cell chemosensitivity and radiosensitivity using single chain intracellular antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5243198A true AU5243198A (en) | 1998-05-22 |
Family
ID=21850270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU52431/98A Abandoned AU5243198A (en) | 1996-10-30 | 1997-10-30 | Enhancement of tumor cell chemosensitivity and radiosensitivity using single chain intracellular antibodies |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU5243198A (en) |
| WO (1) | WO1998018489A1 (en) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7371376B1 (en) | 1996-10-18 | 2008-05-13 | Genentech, Inc. | Anti-ErbB2 antibodies |
| US7262173B2 (en) | 1997-03-21 | 2007-08-28 | Georgetown University | Chemosensitizing with liposomes containing oligonucleotides |
| ZA9811162B (en) | 1997-12-12 | 2000-06-07 | Genentech Inc | Treatment with anti-ERBB2 antibodies. |
| US6417168B1 (en) | 1998-03-04 | 2002-07-09 | The Trustees Of The University Of Pennsylvania | Compositions and methods of treating tumors |
| EP1745799B1 (en) | 1998-03-04 | 2015-09-02 | The Trustees of The University of Pennsylvania | Compositions and methods of treating tumors |
| US20060052321A1 (en) | 2002-04-05 | 2006-03-09 | Raitano Arthur B | Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer |
| US6833438B1 (en) | 1999-06-01 | 2004-12-21 | Agensys, Inc. | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| US20030149531A1 (en) | 2000-12-06 | 2003-08-07 | Hubert Rene S. | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| DK1086223T3 (en) | 1998-06-01 | 2009-11-30 | Agensys Inc | Novel serpentine transmembrane antigens expressed in human cancers and their applications |
| US20040141975A1 (en) | 1998-06-01 | 2004-07-22 | Raitano Arthur B. | Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer |
| EP1165842A4 (en) * | 1999-03-16 | 2004-07-07 | Dana Farber Cancer Inst Inc | LENTIVIRAL VECTOR SYSTEMS FOR SCREENING LARGE QUANTITIES |
| US6949245B1 (en) | 1999-06-25 | 2005-09-27 | Genentech, Inc. | Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies |
| US7041292B1 (en) | 1999-06-25 | 2006-05-09 | Genentech, Inc. | Treating prostate cancer with anti-ErbB2 antibodies |
| DK1244705T3 (en) * | 1999-12-06 | 2010-05-31 | Agensys Inc | Serpentine transmembrane antigens expression in human prostate cancer and its applications |
| AU2406901A (en) * | 2000-01-07 | 2001-07-16 | Makoto Hatakeyama | Method for expressing gene and use thereof |
| EP1282443B1 (en) | 2000-05-19 | 2009-09-02 | Genentech, Inc. | Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy |
| EP1429793B1 (en) | 2001-09-06 | 2015-02-25 | Agensys, Inc. | Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer |
| US7494646B2 (en) | 2001-09-06 | 2009-02-24 | Agensys, Inc. | Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
| PT1742966E (en) | 2004-04-22 | 2014-02-05 | Agensys Inc | Antibodies and molecules derived therefrom that bind to steap-1 proteins |
| UA94899C2 (en) | 2005-01-21 | 2011-06-25 | Дженентек, Инк. | Fixed dosing of her antibodies |
| EP1850874B1 (en) | 2005-02-23 | 2013-10-16 | Genentech, Inc. | Extending time to disease progression or survival in ovarian cancer patients using pertuzumab |
| LT2845866T (en) | 2006-10-27 | 2017-07-10 | Genentech, Inc. | Antibodies and immunoconjugates and uses therefor |
| EP2132573B1 (en) | 2007-03-02 | 2014-04-23 | Genentech, Inc. | Predicting response to a her dimerisation inhbitor based on low her3 expression |
| DK2171090T3 (en) | 2007-06-08 | 2013-06-10 | Genentech Inc | Gene expression markers for tumor resistance to HER2 inhibitor therapy |
| US9551033B2 (en) | 2007-06-08 | 2017-01-24 | Genentech, Inc. | Gene expression markers of tumor resistance to HER2 inhibitor treatment |
| BRPI0812682A2 (en) | 2008-06-16 | 2010-06-22 | Genentech Inc | metastatic breast cancer treatment |
| ES2572728T3 (en) | 2009-03-20 | 2016-06-02 | F. Hoffmann-La Roche Ag | Bispecific anti-HER antibodies |
| CA2761280A1 (en) | 2009-05-29 | 2010-12-02 | F. Hoffmann-La Roche Ag | Modulators for her2 signaling in her2 expressing patients with gastric cancer |
| CN102892779B (en) | 2010-02-18 | 2016-12-21 | 基因泰克公司 | Neuregulin antagonist and the purposes in treatment cancer thereof |
| WO2011146568A1 (en) | 2010-05-19 | 2011-11-24 | Genentech, Inc. | Predicting response to a her inhibitor |
| WO2012069466A1 (en) | 2010-11-24 | 2012-05-31 | Novartis Ag | Multispecific molecules |
| JP5766296B2 (en) | 2010-12-23 | 2015-08-19 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Polypeptide-polynucleotide complexes and their use in targeted delivery of effector components |
| MX2014001766A (en) | 2011-08-17 | 2014-05-01 | Genentech Inc | Neuregulin antibodies and uses thereof. |
| WO2013063229A1 (en) | 2011-10-25 | 2013-05-02 | The Regents Of The University Of Michigan | Her2 targeting agent treatment in non-her2-amplified cancers having her2 expressing cancer stem cells |
| CN106987620A (en) | 2011-11-30 | 2017-07-28 | 霍夫曼-拉罗奇有限公司 | Erbb3 mutation in cancer |
| WO2013083810A1 (en) | 2011-12-09 | 2013-06-13 | F. Hoffmann-La Roche Ag | Identification of non-responders to her2 inhibitors |
| JP2015514710A (en) | 2012-03-27 | 2015-05-21 | ジェネンテック， インコーポレイテッド | Diagnosis and treatment of HER3 inhibitors |
| WO2014083178A1 (en) | 2012-11-30 | 2014-06-05 | F. Hoffmann-La Roche Ag | Identification of patients in need of pd-l1 inhibitor cotherapy |
| US20190151346A1 (en) | 2016-05-10 | 2019-05-23 | INSERM (Institute National de la Santé et de la Recherche Médicale) | Combinations therapies for the treatment of cancer |
| WO2018184966A1 (en) | 2017-04-03 | 2018-10-11 | F. Hoffmann-La Roche Ag | Antibodies binding to steap-1 |
-
1997
- 1997-10-30 AU AU52431/98A patent/AU5243198A/en not_active Abandoned
- 1997-10-30 WO PCT/US1997/019911 patent/WO1998018489A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998018489A1 (en) | 1998-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU5243198A (en) | Enhancement of tumor cell chemosensitivity and radiosensitivity using single chain intracellular antibodies | |
| AU7171098A (en) | Directed evolution of enzymes and antibodies | |
| AU2001236734A1 (en) | Enhancement of tumor cell chemosensitivity and radiosensitivity using single chain secretory antibodies | |
| HUP0002474A3 (en) | Improved anti-ige antibodies and method of improving polypeptides | |
| AU6277498A (en) | Multiple-site antibody capture immunoassays and kits | |
| AU4655296A (en) | Compositions and methods for treating tumor cells | |
| AU5155398A (en) | Anti-ccr5 antibodies and methods of use therefor | |
| AU7237496A (en) | Methods and compositions comprising single chain recombinant antibodies | |
| AU1704099A (en) | Monoclonal human natural antibodies | |
| EP0852627A4 (en) | Cell death protein | |
| AU6142698A (en) | Easy open package and method of making same | |
| AU8298598A (en) | Supported graft and methods of making same | |
| AU1833797A (en) | Multistrand twist cereal pieces and method of preparation | |
| AU6131198A (en) | Isolated mammalian neural stem cells, methods of making such cells, and methods of using such cells | |
| AU5733098A (en) | Inlaid portfolio and method of making | |
| AU3587599A (en) | Single chain monoclonal antibody fusion reagents that regulate transcript ion in vivo | |
| AU7422496A (en) | NM03 antibody materials and methods | |
| AU5428398A (en) | Monoclonal antibodies specific to endothelial cell cadherins and uses thereof | |
| AU1317695A (en) | Conjugates consisting of peptidic t cell antigens and cell binding partners and their use for therapy | |
| AU6109196A (en) | Modified avidin and streptavidin and methods of use thereof | |
| AU696638B2 (en) | Method of assaying antiphospholipid antibody and kit therefor | |
| AU2021597A (en) | Size-sorting trawl and method of using same | |
| AU6580498A (en) | Partition feeder and method | |
| AU7113696A (en) | Detection and quantitation of 8-oh-adenine using monoclonal antibodies | |
| AU6128794A (en) | Methods and kits for determining effects of anti-cancer agents on cancer cells |